01 1Reliance Life Sciences Private Limited
01 1BORTEZOMIB
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-06
Pay. Date : 2018-03-28
DMF Number : 26282
Submission : 2012-08-14
Status : Active
Type : II
20
Reliance Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BORTEZOMIB, with a corresponding US DMF Number 26282.
Remarkably, this DMF maintains an Active status since its submission on August 14, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 06, 2018, and payment made on March 28, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
